• Non ci sono risultati.

3. Dornhoffer JL, Waner M, Arenberg IK: Immunoperoxidase study of the endolymphatic sac in Meniere’s disease. Laryngoscope 103:1027-1034, 1993

N/A
N/A
Protected

Academic year: 2021

Condividi "3. Dornhoffer JL, Waner M, Arenberg IK: Immunoperoxidase study of the endolymphatic sac in Meniere’s disease. Laryngoscope 103:1027-1034, 1993 "

Copied!
32
0
0

Testo completo

(1)

BIBLIOGRAFIA

1. Gates GA: Meniere's disease review 2005. J Am Acad Audiol. 17(1):16- 26. Review, 2006

2. Galey FR, Linthicum FH, Durko T, Rosenblatt S, Motta G, Praterelli M:

Morphometric Analysis of the human Endolympahatic sac. Acta Otolaryngol (Suppl) (Stockh) 459:1-46, 1988

3. Dornhoffer JL, Waner M, Arenberg IK: Immunoperoxidase study of the endolymphatic sac in Meniere’s disease. Laryngoscope 103:1027-1034, 1993

4. Salt AN, DeMott J: Endolymph calcium increases with time after surgical induction of hydrops in guinea pigs. Hearing Res 74:115-121, 1994

5. Wackym PA: Histopatologic findings in Meniere’s disease. Otolaryngol Head Neck Surg 112:90, 1995

6. Lee KS, Kimura RS: Ischemia of the endolymphatic sac. Acta Otolaryngol. 112(4):658-66, 1992

7. Horner KC, Cazals Y: Stress hormones in Meniere's disease and acoustic neuroma. Brain Res Bull. 15;66(1):1-8, 2005

8. Frykholm C, Larsen HC, Dahl N, Klar J, Rask-Andersen H, Friberg U:

Familial Meniere's disease in five generations. Otol Neurotol. 27(5):681- 6, 2006

9. Naganuma H, Kawahara K, Tokumasu K, Okamoto M: Water may cure

patients with Meniere’s disease. Laryngoscope. 116(8):1455-60, 2006

(2)

10. Dornhoffer JL, Arenberg IK: lmmune mechanisms in Meniere's syndrome. Otolaryngol Clin North Am 30:1017-26, 1997

11. Hsu L, Zhu XN, Zhao YS: Immunoglobulin E and circulating immune complexes in endolymphatic hydrops. Ann Otol Rhinol Laryngol. 99:535- 8. Review, 1990

12. Nair TS, Kozma KE, Hoefling NL, Kommareddi PK, Ueda Y, Gong TW, Lomax MI, Lansford CD, Telian SA, Satar B, Arts HA, El-Kashlan HK, Berryhill WE, Raphael Y, Carey TE: Identification and characterization of choline transporter-like protein 2, an inner ear glycoprotein of 68 and 72 kDa that is the target of antibody-induced hearing loss. J Neurosi 18;24(7):1772-9, 2004

13. Harris JP: Immunology of the inner ear: Evidence of local antibody production. Ann Otol Rhinol Laryngol 93:147-162, 1984

14. Wei NR, Helms l, Giebel W: lmmunohistochemical findings in the vestibular ganglion from a patient with Meniere's disease. Eur Arch Otorhinolaryngol 247:340-4, 1990

15. Fattori B, Ghilardi PL, Casani A, Migliorini P, Riente L: Meniere's disease: role of antibodies against basement membrane antigens.

Laryngoscope. 104(10):1290-4, 1994

16. Menière P: Mémoire sur des lésions de l’oreille interne donnant lieu à des symptomes de congestion cérébrale apoplectiforme. Gaz Méd Paris 16:597-601, 1861

17. Atkinson M: Méniere’s original papers reprinted with an English

translation together with commentaries and biographical sketch. Acta

Otolaryngol (Stockh) Suppl 162:1-78, 1961

(3)

18. Deleau N Jr: Des Effets Pathologiques de Quelques Lésions de l’Oreille Moyenne sur les Muscels de l’Expression Faciale, sul l’Organe de la Vue et sur l’Encéphale. Paris: Delanchy, 1838

19. Fluorens P: Expériences sur les canaux sémi-circulaires des oiseaux, lu le 11 Aout 1828. Mém Acad Roy Sci 9:455-466, 1830

20. Baloh RW: Prosper Meniere and his disease. Arch Neurol. 58(7):1151-6, 2001

21. Hinton J: The Questions of Aural Surgery. London: Henry S King & CO, 1874

22. Field GP: Diseases of the Ear. London: Henry Renshaw, 1882

23. Politzer A: The Textbook of the Diseases of the Ear and Adjecent Organs. Philadelphia, PA: Henry C. Lea’s Son & Co, 1883

24. Turner AL (ed): Diseases of the Nose, Throat and Ear For Practioners and Students. Baltimore, MD: William Wood & Co, 1936

25. Guild SR: The circulation of the endolymph. Am J Anat 39:57-81, 1927

26. Portmann, 1927 In: Baloh RW, Halmaggi GM: Disorders of the vestibular system. Oxford University Press, 1996

27. Hallpike C, Cairns H: Observations on the pathology of Ménière’s sindrome. J Laryngol Otol 53:625-655, 1938

28. Yamakawa K: Über die pathologische Veränderung bei einem Meniere- Kranken. J Otorhinolaryngol Soc Jpn 44:2310-2312, 1938

29. Naito, 1950 In: Baloh RW, Halmaggi GM: Disorders of the vestibular

system. Oxford University Press, 1996

(4)

30. Kimura RS, Schuknecht HF: Membranous hydrops in the inner ear of the guinea pig after obliteration of the endolymphatic sac. Pract Otorhinolaryngol. 27:343-354, 1965

31. Wladislavosky-Wasserman P, Facer GW, Mokri B, Kurland LT:

Meniere’s disease: a 30-year epidemiologic and clinical study in Rochester, MN, 1951-1980. Laryngoscope 94:1098-1102, 1984

32. Shojaku H, Watanabe Y, Fujisaka M, Tsubota M, Kobayashi K, Yasumura S, Mizukoshi K: Epidemiologic characteristics of definite Meniere's disease in Japan. A long-term survey of Toyama and Niigata prefectures. ORL J Otorhinolaryngol Relat Spec. 67(5):305-9, 2005

33. Biagini C, Nuti D, Sensini I: Incidence of Meniere's disease in the Siena Local Health Unit 30 area. Acta Otorhinolaryngol Ital. 11(4):379-83, 1991

34. Caparosa RJ: Medical treatment of Meniere’s disease. Laryngoscope 73:666-672, 1963

35. Kitahara M, Futaki T, Nakano K: Ethnic aspect of Meniere’s disease. Int J Equilib Res (Suppl) 1:104-110, 1971

36. Okafor BC: Incidence of Meniere’s disease. J Laryngol Otol 98:775-559, 1984

37. Imoto T, Nakai Y, Stahle J: Meniere’s disease in Uppsala and Osaka.

Acta Otolaryngol (Stockh) 98:519-523, 1984

38. Cawthorne T, Hawlett AB: Meniere’s disease. Proc R Soc Med n47:663- 670, 1954

39. Harrison MS, Naftalin L: Meniere’s disease: Mechanisms and

Management. Springfield, IL: Charles C Thomas, 1968

(5)

40. Stahle J: Advanced Meniere’s disease: a study of 356 severely disabled patients. Acta Otolaryngol (Stockh) 81:113-119, 1976

41. Watanabe Y, Mizukoshi K, Shojaku H, Watanabe I, Hinoki M, Kitahara M: Epidemiological and clinical characeristics of Meniere’s disease in Japan. Acta Otolaryngol (Stockh) Suppl 519:206-210, 1995

42. Thomas K, Harrison MS: Long-term follow-up of 610 cases of Meniere’s disease. Proc R Soc Med 64:853-857, 1971

43. Castellano R: Meniere’s disease and its surgical treatment: report of 300 cases. Neurosurgery 8:173-179, 1951

44. Enander A, Stahle J: Hearing in Meniere’s disease: a study of pure-tone audiograms in 334 patients. Acta Otolaryngol (Stockh) 64:543-556, 1967

45. Friberg U, Stahle J, Svedberg A: The natural corse of Meniere’s disease.

Acta Otolaryngol (Stockh) Suppl 406:72-77, 1984

46. House JW, Doherty JK, Fisher LM, Derebery MJ, Berliner KI: Meniere's disease: prevalence of contralateral ear involvement. Otol Neurotol.

27(3):355-61, 2006

47. Kitahara M, Kitano H, Suzuki M: Meniere’s disease with bilateral fluctuant hearing loss. In: Kitahara M (ed) Meniere’s disease, pp 13-19.

Tokyo: Springer-Verlag, 1990

48. Watanabe Y: Incidence of Meniere’s disease, including some other

epidemiological data. In: Osterveld WJ (ed) Meniere’s disease: A

Comprehensive Appraisal, pp 9-23. Chichester/New

York/Brisbane/Toronto/Singapore: John Wiley & Sons, 1983

(6)

49. Liu Chan: Beijing Institute of Otolaryngology, PR China. Personal Communication, 1996

50. Xue Shan-yi: General Hospital of Air Force Beijing, PR China. Personal communication, 1996

51. Mizukoshi K, Ino H, Ishikawa K, Watanabe Y, Yamazaki H, Kato I, Okubo J, Watanabe I: Epidemiological survey of definite cases of Meniere’s disease collected by the seventeen members of the Meniere’s disease research committee of Japan in 1975-1976. Adv Otorhinolaryngol 25:106-111, 1979

52. Naito T: Clinical studies of Meniere’s disease. Rav Laryngol Otol Rhinol (Bordeaux) 83:361-383, 1962

53. Celestino D, Ralli G: Incidence of Menier’es disease in Italy. Am J Otol 12:135-138, 1987

54. Hallpike CS, Wright AJ: On the histological changes in the temporal bones of a case of Ménière’s disease. J Laryngol Otol 55:59-66, 1940

55. Lindsay JR: Labyrinthine dropsy and Ménière’s disease. Arch Otolaryngol 37:853-867, 1942

56. Altmann F, Fowler EP Jr: Histological findings in Ménière’s symptom complex. Ann Otol Rhinol Laryngol 52:52-80, 1943

57. Schuknecht HF, Benitz JT, Beekhius J: Further observations of the pathology of Menière’s disease. Ann Otol Rhinol Laryngol 71:1039-1053, 1962

58. Stahle J, Wilbrand H: The vestibular aqueduct in patients with Meniere’s

disease: a tomographic and clinical investigation. Acta Otolaryngol

(Stockh) 78:36-48, 1974

(7)

59. Yazawa Y, Kitahara M: Computerized tomography of the petrus bone in Meniere’s disease. Acta Otolaryngol (Stockh) Suppl 510:67-72, 1994

60. Paparella MM, Mancini F, Liston SL: Otosclerosis and Ménière’s syndrome: diagnosis and treatment. Laryngoscope 94:1414-1417, 1984

61. Schuknecht HF: Pathology of the ear, 2nd Edn. Philadelphia, PA: Lea &

Febiger, 1993

62. Sando I, Ikeda M: The vestibular aqueduct in patients with Meniere’s disease. A temporal bone histopathological investigation. Acta Otolaryngol (Stockh) 97:558-570, 1984

63. Smith CA, Lowry OH, Wu M-L: The electrolytes of the labyrinthine fluids.

Laryngoscope 64:141-153, 1954

64. Tasaki I, Davis H, Eldredge DH: Exploration of cochlear potentials in guinea pig with a microelectrode. J Acoust Soc Am 26:765-773, 1954

65. Schuknecht HF, Northrop C, Igarashi M: Cochlear pathology after destruction of the endolymphatic sac in the cat. Acta Otolaryngol (Stockh) 65:479-487, 1968

66. Zenner HP, Reuter G, Zimmermann U, Gitter AH, Fermin C, LePage EL:

Transitory endolymph leakage induced hearing loss and tinnitus:

depolarization, biphasic shortening and loss of electromotility of outer hair cells. Eur Arch Otorhinolaryngol 251(3):143-53; 1994

67. Kimura RS, Schuknecht HF: Effect of fistulae on endolymphatic hydrops.

Ann Otol Rhinol Laryngol 84:271-286, 1975

68. Schuknecht HF, Rüther A: Blockage of longitudinal flow in

endolymphatic hydrops. Eur Arch Otorhinolaryngol 248:209-217, 1991

(8)

69. Nadol JB Jr: Positive Hennebert’s sign in Meniere’s disease. Arch Otolaryngol 103:524-530, 1977

70. Sando I, Ikeda M: The vestibular acqueduct in patients with Meniere’s disease. In: Vosteen K-H (ed) Meniere’s Disease: Pathogenesis, Diagnosis and Treatment, pp 141-147. Stuttgart: Gorge Thieme Verlag, 1981

71. Hebbar GK, Rask-Andersen H, Linthicum F: Three-dimensional analysis of 61 human endolymphatic ducts and sacs in ears with and without Meniere's disease. Ann Otol Rhinol Laryngol 100:219-225, 1991

72. Stahle l, Wilbrand HF: The vestibular aqueduct in patients with Meniere's disease. Acta Otolaryngol (Stockh) 78:36-48, 1974

73. Plantenga KF, Browning GG: The vestibular aqueduct and endolymphatic sac and duct in endolymphatic hydrops. Arch Otolaryngol 105:546-553, 1979

74. Rizvi SS, Smith LE: Idiopathic endolymphatic hydrops and the vestibular aqueduct. Ann Otol Rhinol Laryngol 90:77-79, 1981

75. Galey FR: Quantitative evaluation of the structure of the endolymphatic sac. In: Nadol Jr JB (ed) Meniere's Disease, pp 105-111.

Amsterdam/Berkeley/Milano: Kugler& Ghedini Publ, 1989

76. Saito H, Kitahari M, Yasawa Y, Matsumoto M: Histopathologic findings in

surgical specimens of endolymphatic sac in Meniere's disease. Acta

Otolaryngol (Stockh) 83:463-469, 1977

(9)

77. Schindler RA, Horn KL, Leaky-Jones P, Maglio M: The ultrastructure of the endolymphatic sac in Meniere's disease. Laryngoscope 89:95-107, 1979

78. Altmann F, Kornfeld M: Histological studies of Meniere's disease. Ann Otol Rhinol Laryngol 75:915-943, 1965

79. Yamakawa K: Pathologic changes in a Meniere’s patient. In:

Proceedings in the 42nd Meeting of the Japanese Otorhinolaryngology Society, pp 2310-2312, 1938

80. Lim DJ, Glasscock ME III: Fine morphology of the endolymphatic sac in Meniere's disease. In: Vosteen K-H (ed) Meniere's Disease:

Pathogenesis, Diagnosis and Treatment, pp 115-127. Stuttgart: George Thieme Verlag, 1981

81. Lee AJ, Parker DA, Gladstone HB, Hradek G, Schindler RA: Effects of endolymphatic duct occlusion on the structure and function of the endolymphatic sac in the adult guinea pig. Laryngoscope 105:192-197, 1995

82. Sando I, Ikeda M: Pneumatization and thickness of the petrous bone in patients with Meniere's disease: a histopathological study. Ann Otol Rhinol Laryngol 94 (Suppl 118):2-5, 1985

83. Willbrand FH, Stahle J: Temporal bone in patients with Meniere’s disease. In: Vosteen K-H (ed) Meniere’s Disease. Pathogenesis, Diagnosis and Treatment, pp 141-147. Stuttgart: Georg Thieme Verlag, 1981

84. Yasawa Y, Kitahara M: Computed tomographic findings around the

vestibular aqueduct in Meniere's disease. Acta Otolaryngol (Stockh)

Suppl 481:88-90, 1991

(10)

85. Kraus EM, Dubois Pl: Tomography of the vestibular aqueduct in ear disease. Arch Otolaryngol 105:91-98, 1979

86. Sackett lF, Strother CM, Arenberg IK, Goldman G: The vestibular aqueduct: tomograph evaluation in Meniere's disease: a preliminary report. Head Neck Surg 2:282-286, 1980

87. Gussen R: Endolymphatic hydrops with absence of vein in paravestibular canaliculus. Ann Otol Rhinol Laryngol 89:157-161, 1980

88. Belal A: The effects of vascular occlusion on the human inner ear. J Laryngol Otol 93:955-968, 1979

89. Kelemen G: Anatomical observations on the distal extremity of the vestibular aqueduct. J Laryngol Otol 90: 1071-1079, 1976

90. Bachor E, Karmody CS: The utriculo-endolymphatic valve in children: a temporal bone histopathological study. In: Filipo R (ed) Meniere's Disease: Perspectives in the '90s, pp 227-229, Proceedings of the Third International Symposium on Meniere's Disease, Rome, 1993

91. Danckwardt-Lillieström N, Friberg U, Kinnefors A, Rask-Andersen H:

'Endolymphatic saccitis' in a case of active Meniere's disease. Ann Otol Rhinol Laryngol 106(3):190-8, 1996

92. Rydmarker S, Horner KC: Morphological changes of hair cell stereocilia and tectorial membrane in guinea pig with experimentally induced hydrops. Scanning Electron Microscopy 4:705-714, 1990

93. Silverstein H: Biochemical and physiologic studies of the endolymphatic sac in the cat. Laryngoscope 76:498-512, 1966

94. Miyamoto H, Morgenstern C: Role of electrolytes in different parts of the

endolymphatic space In: Vosteen K-H, Schuknecht HF, Pfaltz CR,

(11)

Wersall J, Kimura RS, Morgenstern C, Juhn SK (ed) Meniere's Disease, International Symposium, pp 39-43. New York, NY: Georg Thieme Verlag, 1981

95. Wackym PA, Friberg U, Bagger-Sjöbäck D, Rask-Andersen H: Human endolymphatic duct: possible mechanisms of endolymph outflow. Ann Otol Rhinol Laryngol 95:409-414, 1986

96. Rask-Andersen H, Bagger-Sjöbäck D, Lundquist P-G: The fenestrated blood vessels of the endolymphatie sac: a freeze-fracture and TEM study. Am J Otol 4:214-221, 1983

97. Erwall C: General effects of hyperosmolar agents on the endolymphatic sac. Hear Res 36:277-286, 1988

98. Erwall C, Takumida M, Bagger-Sjöbäck D, Rask-Andersen H, Wroblewski J: Uptake of radioactive sulphur in the endolymphatic sac.

Acta Otolaryngol (Stockh) 107:63-70, 1989:

99. Frömter E: Solute and water transport across epithelia. In: Vosteen K-H, Schuknecht H, Pfaltz CR, Wersall J, Kimura RS, Morgenstern C, Juhn SK (ed) Meniere's Disease, International Symposium, pp 23-31. New York, NY: Georg Thieme Verlag, 1981

100. Bagger-Sjöbäck D, Rask-Andersen H, Lundquist PO: Intercellular junctions in the epithelium of the endolymphatic sac: a freeze-fracture and TEM study on the guinea pig's labyrinth. In: Vosteen K-H, Schuknecht H, Pfaltz CR, Wersall J, Kimura RS, Morgenstern C, Juhn SK (ed) Meniere’s Disease, Inernational Symposium, pp 127-140. New York, NY: Georg Thieme Verlag, 1981

101. Bagger-Sjöbäck D, Jansson B, Friberg D, Rask-Andersen H: The three

dimensional anatomy of the human endolymphatic sac. Arch Otolaryngol

Head Neck Surg 116:345-349, 1990

(12)

102. Lundquist PG, Kimura R, Wersall I: Experiments in endolymph circulation. Acta Oto-Laryngol (Suppl) 188:194-201, 1964

103. Naftalin L, Spencer Harrison M: Circulation of labyrinthine fluids. J Laryngol Otol 72:118-136, 1958

104. Konishi T, Hamrick PE, Walsh Pl: Ion transport in the guinea pig cochlea. Potassium and sodium transport. Acta Otolaryngol (Stockh) 86:22-34, 1978

105. Salt AN, Thalmann R, Marcus DC, Bohne BA: Direct measurement of endolymph flow rate in the guinea pig cochlea. Hearing Res 23:141-151, 1986

106. Salt AN, Thalmann R: Rate of longitudinal flow of cochlear endolymph.

In: Nadol JB Jr (ed) Meniere's Disease, pp 69-73. Amsterdam/Milano:

Kugler & Ghedini Publ, 1989

107. Sziklai I, Ferrary E, Homer KC, Sterkers O, Amiel C: Time-related alteration of endolymph composition in an experimental model of endolymphatic hydrops. Laryngoscope 102:431-438, 1992

108. Salt AN, DeMott JE: Endolymph volume changes during osmotic dehydration measured by two marker techniques. Hearing Res 90:12-23, 1995

109. Friberg U, Wackym PA, Bagger-Sjöbäck D, Rask-Andersen H: Effect of labyrinthectomy on the endolymphatic sac. Acta Otolaryngol (Stockh) 101:172-182, 1986

110. Takumida M, Bagger-Sjöbäck D, Rask-Andersen H: The endolymphatic

sac and inner ear homeostasis. Effect of glycerol on the endolymphatic

sac with or without colchicine pretreatment. Hearing Res 40:1-16, 1989

(13)

111. Böhmer A, Andrews lC: Maintenance of hydrostatic pressure gradients in the membranous labyrinth. Arch Otorhinolaryngol 246:65-66, 1989

112. Carlborg BIR, Konradsson KS, Carlborg AH, Farmer JE, Densert O : Pressure transfer between the perilymph and the cerebrospinal fluid compartments in cats. Am J Otolaryngol 13:41-48, 1992

113. Long CH, Morizono T: Hydrostatic pressure measurements of endolymph and perilymph in a guinea pig model of endolymphatic hydrops. Otolaryngol Head Neck Surg 96:83-95, 1987

114. Andrews JC, Böhmer A, Hoffman LF: The measurement and manipulation of intralabyrinthine pressure in experimental endolymphatic hydrops. Laryngoscope 101:661-668, 1991

115. Takeda T, Kakigi A, Saito H: Antidiuretic hormone (ADH) and endolymphatic hydrops. Acta Otolaryngol (Stockh) Suppl 519:219-222, 1995

116. Pitovski DZ, Drescher MI, Kerr TP, Drescher DG: Aldosterone mediates an increase in

3

H-ouabain binding at Na+, K+-ATPase sites in the mammalian inner ear. Brain Res 601:273-278, 1993

117. Itoh A, Sakata E: treatment of vestibular disorders. Acta Otolaryngol (Stockh) Suppl 481:617-623, 1991

118. Shea JJ Jr, Ge X: Dexamethasone perfusion of the labyrinth plus intravenous dexamethasone for Meniere's disease. Otolaryngol Clin N Am 29:353-358, 1996

119. Julien N, Loiseau A, Sterkers O, Amiel C, Ferrary E: Antidiuretic

hormone restores the endolymphatic longitudinal K gradients in the

Brattleboro rat cochlea. Pflügers Arch 426:446-452, 1994

(14)

120. Bartoli E, Satta A, Melis F, Caria MA, Masala W, Vargiu G, Melini F, Teatini GP, Azzena GB: Volume receptors in guinea pig labyrinth:

relevance with respect to ADH and Na controI. Am J Physiol 257:F341- F346, 1989

121. Ma YL, Gerhardt KI, Curtis LM, Rybak LP, Whitworth C, Rarey KE:

Combined effects of adrenalectomy and noise exposure on compound action potentials, endocochlear potentials and endolymphatic potassium concentrations. Hearing Res 91:79-86, 1995

122. Ferrary E, Bernard C, Teixeira M, Julien N, Bismuth P, Couloigner V:

Ionic control of volume and pressure regulation in the labyrinth. In: Ernst A, Marchbanks R, Samii M (eds) Intracranial and Intralabyrinthine Fluids, pp 39-43. Heidelberg: Springer Verlag, 1996

123. Qvortrup K, Rostgaard I, Holstein-Rathlou N: The inner ear produces a natruretic hormone. Am J Physiol 270: F1073-F1077, 1996

124. Andrews JC, Ator GA, Honrubia V: The exacerbation of symptoms in Meniere's disease during the premenstrual period. Arch Otolaryngol Head Neck Surg 118:74-78, 1992

125. Erwall C, Friberg U, Bagger-Sjöbäck D et al: Degradation of the homogeneous substance in the endolymphatic sac. Acta Otorinolaryngol (Stockh) 105:209, 1988

126. Takumida M, Bagger-Sjöbäck D, Rask-Andersen H: Cytochemical identification of secreted carbohydrates in the endolymphatic sac. Acta Otolaryngol (Stockh) 106:417, 1988 a)

127. Takumida M, Bagger-Sjöbäck D, Rask-Andersen H: Ruthenium red

staining of the endolymphatic sac in the guinea pig. J Laryngol Otol

102:760, 1988 b)

(15)

128. Wackym PA, Linthicum FH, Ward PH, et al: Re-evaluation of the role of the human endolymphatic sac in Meniere’s disease. Otolaryngol Head Neck Surg 102:732, 1990

129. Smith RJ, Coppale KB, Ankerstjerne JKB, Capper DT, Kumar S, Kenyon J, Tinley S, Comeau K, Kimberling WJ: Localization of the gene for branchiootorenal sindrome to chromosome 8q. Genomics 14:841-844, 1992

130. Arweiler DJ, Jahnke K, Grosse-Wilde H: Meniere disease as an autosome dominant hereditary disease Laryngorhinootologie 74(8):512- 5, 1995

131. Perez Lopez L, Belichton de Diego A, Bermell Carrion A, Perez Garrigues H, Morera Perez C: Meniere's disease and migraine. Acta Otorrinolaringol Esp 57(3):126-9, 2006

132. Doi K, Sato T, Kuramasu T, Hibino H, Kitahara T, Horii A, Matsushiro N, Fuse Y, Kubo T: Meniere's disease is associated with single nucleotide polymorphisms in the human potassium channel genes, KCNE1 and KCNE3. ORL J Otorhinolaryngol Relat Spec. 67(5):289-93, 2005

133. Cate WJ, Curtis LM, Rarey KE: Effects of low-sodium, high-potassium dietary intake on cochlear lateral wall Na+,K(+)-ATPase. Eur Arch Otorhinolaryngol 251(1):6-11, 1994

134. Vrabec JT: Herpes simplex virus and Meniere's disease. Laryngoscope 113(9):1431-8, 2003

135. Calenoff E, Zhao J-C, Derlacki EL, et al: Patiens with Meniere’s disease

possess IgE reacting with herpes family viruses. Arch Otolaryngol Head

Neck Surg 121:861, 1995

(16)

136. Arnold W, Niedermeyer HP: Herpes Simplex Virus antibodies in the perilymph of patiens with Meniere’s disease. Arch Otolaryngol Head Neck Surg 123:53, 1997

137. Xenellis J, Morrison AW, McClowskey D, Festenstein H, Path FRC: HLA antigens in the pathogenesis of Meniere’s disease. The Journal of Laryngology and Otology 100(1)21-4, 1986

138. Bowman C, Nelson R: HLA antigens in autoimmune sensorineural hearing loss. Laryngoscope, 97:7, 1987

139. Rask-Andersen H, Bredeberg G, Stahle J: Structure and function of the endolymphatic duct. In: Vosteen KH et al. Meniere’s disease. G. Thieme Verlag, Stuttgart, 1981

140. Mogi G, Kawauchi H, Suzuki M, Sato N: Inner ear immunology.

American Journal of Otolaryngology 6(3):142-7, 1985

141. Kumagagni H, Nishida H, Dohl K: Experimental labyrinthine lesions through styloid foramen. ORL J Otorhinolaryngol Relat Spec 38(6):334- 43, 1986

142. Woolf NK, Harris JP: Cochlear pathophysiology associated with inner ear immune responses. Acta Oto-Laryngologica (Stockh) 102(5-6):353- 64, 1986

143. Fukuda S, Keithley EM, Harris JP: The development of endolymphatic hydrops due to CMV infection of the endolymphatic sac and associated anti-viral inner ear immune responses. Laryngoscope 98(4):439-43, 1988

144. Meyer zum Gottesberge AM, Kaufmann R: Is an imbalance of calcium

homeostasis responsible for experimentally induced endolymphatic

hydrops? Acta Otolaryngol 102:93-98, 1986

(17)

145. Angelborg C, Klockhoff I, Stahle J: Serum osmolality in patients with Meniere's disease. Acta Otolaryngol 76(6):450-4, 1973

146. Gussen R: Vascular mechanisms in Meniere's disease. Otolaryngol Head Neck Surg 91(1):68-71, 1983

147. Zechner G, Altmann F: Histological studies on the human endolymphatic duct and sac. Pract Oto-Rhino-Laryngol, 31: 65-83, 1969

148. Kitano H, Takeda T, Pulec JL, Saadat D, Uchida K: The relationship between vasopressin and endolymphatic hydrops in the guinea pig. Ear Nose Throat J 73(12):921-5, 1994

149. Rarey KE, Tyneway D, Patterson K: Adrenocorticosteroid regulation of the inner ear Na-K-ATPase activity. In: Nadol JB Jr (ed) Meniere’s Disease, pp 173-176. Amsterdam/Berkeley/Milano: Kugler & Ghedini Publ, 1989

150. Sterkers O, Ferrary E, Amiel C: Inter- and intracompartimental osmotic gradients within the rat coclea. Am J Physiol 247:F602-F606, 1984

151. Hinchcliffe R: Emotion as a precipitative factor in Meniere’s disease. J Laryngol Otol 81:471-475, 1967 a)

152. Lucente F: Psychiatric problems in otolaryngology. Ann Otol Rhinol Laryngol 82:340-346, 1973

153. Wexler M, Crary WG: Meniere’s disease: the psychomatic hypothesis.

Am J Otol 7:93-96, 1986

154. Hinchcliffe R: Personality profile in Meniere’s disease. J Laryngol Otol

81:47-481, 1967 b)

(18)

155. Groen JJ: Psychosomatic aspects of Meniere’s disease. Acta Otolaryngol (Stockh) 95:407-416, 1983

156. Ryan AF, Keithley EM, Harris JP: Autoimmune inner ear disorders. Curr Opin Neurol 14(1):35-40. Review, 2001

157. Giani T, Simonini G, Lunardi C, Puccetti A, De Martino M, Falcini F:

Juvenile psoriatic arthritis and acquired sensorineural hearing loss in a teenager: is there an association? Clin Exp Rheumatol 24(3):344-6, 2006

158. Rajan TV: The Gell-Coombs classification of hypersensitivity reactions: a re-interpretation. Trends Immunol 24(7):376-9, 2003

159. Arenberg IK, Marovitz W, Shambaugh GE: The role of endolymphatic sac in the pathogenesis of endolymphatic hydrops in man. Acta Otolaryngol Suppl (Stockh) 275:1-49, 1970

160. Rask-Anderson H, Stahle J: Immunodefence of the inner ear?

Lymphocyte-macrophage interaction in the endolymphatic sac. Acta Otolaryngol (Stockh) 89:283-294, 1980

161. Leone CA, Feghali JG, Linthicum FH Jr: Endolymphatic sac: Possibile role in autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol 93:208-209, 1984

162. Arenberg IK, Norbach DH, Shambaugh GE Jr: Ultrastructural analysis of endolymphatic sac biopsies. Arch Otolaryngol Head Neck Surg 108:292- 298, 1982

163. Arenberg IK, Norbach DH, Shambaugh GE Jr: Distribution and density of

subepithelial collagen in the endolymphatic sac in patients with

Meniere’s disease. Am J Otol 6:449-545, 1985

(19)

164. Soliman AM: Immune-mediated inner ear disease. Am J Otol 13:575- 579, 1992

165. Harris JP, Sharp PA: Inner ear autoantibodies in patients with rapidly progressive sensorineural hearing loss. Laryngoscope 100(5):516-24, 1990

166. Billings PB, Keithley EM, Harris JP: Evidence linking the 68 kilodalton antigen identified in progressive sensorineural hearing loss patient sera with heat shock protein 70. Ann Otol Rhinol Laryngol 104(3):181-8, 1995

167. Riente L, Bongiorni F, Nacci A, Migliorini P, Segnini G, Delle Sedie A, Ursino F, Tommasi S, Fattori B: Antibodies to inner ear antigens in Meniere's disease. Clin Exp Immunol 135(1):159-63, 2004

168. Cao MY, Gersdorff M, Deggouj N, Warny M, Tomasi JP. Detection of inner ear disease autoantibodies by immunoblotting. Mol Cell Biochem.

146(2):157-63, 1995

169. Kulkens T, Bolhuis PA, Wolterman RA, Kemp S, te Nijenhuis S, Valentijn LJ, Hensels GW, Jennekens FG, de Visser M, Hoogendijk JE, et al:

Deletion of the serine 34 codon from the major peripheral myelin protein P0 gene in Charcot-Marie-Tooth disease type 1B. Nat Genet. 5(1):35-9, 1993

170. Passali D, Damiani V, Mora R, Passali FM, Passali GC, Bellussi L: P0 antigen detection in sudden hearing loss and Meniere's disease: a new diagnostic marker? Acta Otolaryngol 124(10):1145-8, 2004

171. Nuti D, Biagini C, Salerni L, Gaudini E, Passali GC: Use of mammalian

inner ear antigens for the diagnosis of autoimmune sudden loss of

vestibular function. Acta Otolaryngol Suppl (548):34-7, 2002

(20)

172. Cheng KC, Matsuoka H, Lee KM, Kim N, Krug MS, Kwon SS, Mora M, Yoo TJ: Proto-oncogene Raf-1 as an autoantigen in Meniere's disease.

Ann Otol Rhinol Laryngol 109(12Pt 1):1093-8, 2000

173. Boulassel MR, Deggouj N, Tomasi JP, Gersdorff M: Inner ear autoantibodies and their targets in patients with autoimmune inner ear diseases. Acta Otolaryngol 121(1):28-34, 2001

174. Du X, Mora R, Barbieri M, Yoo T: TUNEL-positive labeling in mouse inner ear caused by tubulin immunization is not apoptosis. ORL J Otorhinolaryngol Relat Spec 65(1):17-21, 2003

175. Slepecky NB, Henderson CG, Saha S: Post-translational modifications of tubulin suggest that dynamic microtubules are present in sensory cells and stable microtubules are present in supporting cells of the mammalian coclea. Hear Res 91(1-2):136-47, 1995

176. Furness DN, Hackney CM, Steyger PS: Organization of microtubules in cochlear hair cells. J Electron Microsc Tech. 15(3):261-79, 1990

177. Yoo TJ, Shea J Jr, Ge X, Kwon SS, Yazawa Y, Sener O, Mora F, Mora R, Mora M, Barbieri M, Du X: Presence of autoantibodies in the sera of Meniere's disease. Ann Otol Rhinol Laryngol 110(5 Pt 1):425-9, 2001

178. Tagawa Y, Yuki N, Hirata K: The 301 to 314 amino acid residue of beta- tubulin is not a target epitope for serum IgM antibodies in chronic inflammatory demyelinating polyneuropathy. J Neurol Sci 1;163(1):44-6, 1999

179. Yoo TJ, Tomoda K: Type II collagen distribution in rodents.

Laryngoscope. 98(11):1255-60, 1988

180. Ishibe T, Choe IS, Yoo TJ: Type II collagen distribution in the ear of the

developing chick embryo. Laryngoscope. 99(5):547-53, 1989

(21)

181. Yoo TJ, Stuart JM, Kang AH, Townes AS, Tomoda K, Dixit S: Type II collagen autoimmunity in otosclerosis and Meniere's Disease. Science 217(4565):1153-5, 1982

182. Soliman AM: Type II collagen-induced inner ear disease: critical evaluation of the guinea pig model. Am J Otol 11(1):27-32, 1990

183. Matsuoka H, Kwon SS, Yazawa Y, Barbieri M, Yoo TJ Induction of endolymphatic hydrops by directly infused monoclonal antibody against type II collagen CB11 peptide. Ann Otol Rhinol Laryngol 111(7 Pt 1):587- 92, 2002

184. Futaki T, Shju M: Immunohistochemical analysis of the lateral wall of the endolymphatic sac of patients with Meniere’s disease. Equilibrium Research Complemet 4:31-36, 1988

185. Yazawa Y, Kitahara M: Immunofluorescent study of the endolymphatic sac in Meniere’s disease. Acta Otolaryngol Suppl (Stockh) 468:71-76, 1989

186. Campbell SM, Montanaro A, Bardana EJ: Head and neck manifestations of autoimmune disease. Am J Otolaryngol 4:187, 1983

187. Shea JJ: Autoimmune sensorineural hearing loss as an aggravative factor in Meniere’s disease. Adv Otorhinolaryngol 30:254-257, 1983

188. Bowman CA, Linthicum FH Jr, Nelson RA, et al: Sensorineural hearing loss associated with systemic lupus erythematosus. Otolaryngol Head Neck Surg 94:197, 1986

189. Kempf HG: Ear involvement in Wegener’s granulomatosis. Clin

Otolaryngol 14:451-456, 1989

(22)

190. Tomoda K, Suzuka Y, Iwai H, Yamashita T, Kumazawa T: Meniere's disease and autoimmunity: clinical study and survey. Acta Otolaryngol Suppl 500:31-4, 1993

191. Hoghes GB, Kinney SE, Barna BP, et al: Autoimmune reactivity in Cogan’s syndrome. A preliminary report. Otolaryngol Head Neck Surg 91:24, 1983

192. Barna BP, Hoghes GH: Autoimmunity and otologic disease; Clinical and experimental aspects. Clin Lab Med 8:385-398, 1988

193. Tiwari JL, Terasaki PI: HLA-DR and disease associations. Prog Clin Biol Res 58:151-63. Review, 1981

194. Matsuki K, Harada T, Juji T, Kanzaki J, Koga K, Toriyama M; Human leukocyte antigen in childhood unilateral deafness. Arch Otolaryngol Head Neck Surg 115(1):46-7, 1989

195. Steuer MK, Gross M, Matthias R, Mauff G: Early onset sensorineural hearing loss: association studies with major histocompatibility class III (complement) markers. Am J Otol 11(5):326-9, 1990

196. Bumm P, Muller EC, Grimm-Muller U, Schlimok G: T-lymphocyte subpopulation and HLA-DR antigens in hearing loss of vestibular neuropathy, Meniere's diseases and Bell's palsy. Laryngorhinootologie 70(5):260-6, 1991

197. Cao MY, Thonnard J, Deggouj N, Gersdorff M, Philippe M, Osselaer JC,

Tomasi JP: HLA class II-associated genetic susceptibility in idiopathic

progressive sensorineural hearing loss. Ann Otol Rhinol Laryngol

105(8):628-33, 1996

(23)

198. Bernstein JM, Shanahan TC, Schaffer FM: Further observations on the role of the MHC genes and certain hearing disorders. Acta Otolaryngol 116(5):666-71: 1996

199. Hughes GB, Barna BP, Kinney SE, et al: Clinical diagnosis of immune inner ear disease. Laryngoscope 98:251-253, 1988

200. Veldman JE, Hanada T, Meeusen F: Diagnostic and therapeutic dilemmas in rapidly progressive sensorineural hearing loss and sudden deafness. A reappraisal of immune reactivity in inner ear disorders. Acta Otolaryngol 113(3):303-6, 1993

201. Weetman Ap, McGregor AM: Autoimmune thyroid disease: further developments in our understanding. Endocr Rev 15:788, 1994.

202. Dunn JT, Dunn AD: Thyroglobulin: chemistry, biosynthesis and proteolysis. In: Braverman LE, Utiger LD, eds. Wérner and lngbar's The thyroid: a fundamental and clinical text. 8th ed. Philadelphia: Lippincott Williams & Wilkins, 2000

203. Tomer Y: Anti-thyroglobulin auroantibodies in autoimmune thyroid diseases: cross-reactive or pathogenic? Clin Immunol ImmunopathoI 82:3, 1997

204. Druetta L, Bornet H, Sassolas G, et al: Identification of thyroid hormone residues on serum thyroglobulin: a clue to the source of circulating Thyroglobulin in thyroid diseases. Eur J Endocrinol 140:457, 1999.

205. Marinò M, Chiovato L, Mitsiades N, et al: Circulating thyroglobulin derived from transcytosis is combined with a secretory component of its endocytic receptor megalin. J Clin Endocrinol Metab 85:3458, 2000

206. Rose NR, Burek CL: Autoantibodies to thyroglobulin in health and

disease. Appl Biochem BiotechnoI 83:245, 2000

(24)

207. Chiovato L, Latrofa F, Braverman LE, et al: Disappearance of humoral thyroid autoimmuniry arfter complete removal of thyroid antigens. Ann Intern Med 139:346-51, 2003

208. Caturegli P, Kuppers RC, Mariotti S, al: IgG subclass distribution of thyroglobulin antibodies in patients with thyroid disease. Clin Exp ImmunoI 98:464, 1994

209. Dietrich G, Kazatchkine MD: Normal immunoglobulin G (IgG) far therapeuric use (intravenous Ig) contain anti-idiotypic specificities against an immunodominant, disease associated, cross-reactive, idiotype of human anti-thyroglobulin autoantibodies. J Clin Invest 85:620, 1990

210. Nakamura RM, Weigle WO: Transfer of experimental autoimmune thyroiditis by serum from thyroidectomized donors. J Exp Med 130:263, 1969

211. McLachlan SM, Rapoport B: The molecular biology of thyroid peroxidase: cloning, expression and role as auroantigen in autoimmune thyroid disease. Endocr Rev 13:192, 1992

212. McLachlan SM, Rapoport B: Autoimmune response to the thyroid in humans: thyroid peroxidase-the common autoantigenic denominator. Int Rev Immunol 19:587, 2000

213. Tonacchera M, Cetani F, Costagliola S, et al: Mapping thyroid peroxidase epitopes using recombinant protein fragments. Eur J EndocrinoI 132:53, 1995

214. Grennan Jones F, Ziemnicka K, Sanders J, et al: Analysis of

autoantibody epitopes on human thyroid peroxidase. Autoimmunity

30:157, 1999

(25)

215. Spencer CA: Thyroglobulin. In: Braverman LE, Utiger LD, eds. Werner and Ingbar's The thyroid: a fundamental and clinical text. 8th ed.

Philadelphia: Lippincott Williams & Wilkins, 2000:402

216. Chiovato L, Bassi P, Santini F, et al: Antibodies producing complement- mediated thyroid cytotoxicity in patients with atrophic or goitrous autoimmune thyroiditis. J Clin Endocrinol Metab 77:1700, 1993

217. Bogner D, Kotulla P, Peters H, et al: Thyroid peroxidase/microsomal antibodies are not identical with thyroid cytotoxic antibodies in autoimmune thyroiditis. Acta Endocrinol (Copenh) 123:431, 1990

218. Kalderon AE, Bogaars HA: Immune complex deposits in Graves' disease and Hashimoto's thyroiditis. Am J Med 63:729, 1977

219. Rapoport B, Chazenbalk GD, Jaume JC, et al: The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies. Endocr Rev 19:673, 1998

220. Graves PN, Davies TE: New insights into the thyroid-stimulating hormone receptor. The major antigen of Graves' disease. Endocrinol Metab Clin North Am 29:267, 2000

221. Tokuda Y, Kasagi K, Iida Y, et al: Inhibition of thyrotropin-stimulated iodide uptake in FRTL-5 thyroid cells by crude immunoglobulin fractions from patients with goitrous and atrophic autoimmune thyroiditis. J Clin Endocrinol Metab 67:251, 1988

222. Akamizu T, Kohn LD, Hiratani H, et al: Hashimoto s thyroiditis with

heterogeneous antithyrotropin receptor antibodies: unique epitopes may

contribute to the regulation of thyroid function by the antibodies. J Clin

Endocrinol Metab 85:2116, 2000

(26)

223. Costagliola S, Morgenthaler NG, Hoermann R, et al: Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease. J Clin Endocrinol Metab 84:90, 1999

224. Chiovato L, Vitti P, Santini F, et al: Incidence of antibodies blocking thyrotropin effect in vitro in patients with euthyroid or hypothyroid auroimmune thyroiditis. J Clin Endocrinol Metab 71:40, 1990

225. Chiovato L, Vitti P, Bendinelli G, et al: Detection of antibodies blocking thyrotropin effect using Chinese hamster ovary cells transfected with the cloned human TSH recepror. J Endocrinol Invest 17:809, 1994

226. Vitti P, Rotella CM, Valente WA, et al: Characterization of the optimal stimularory effect of Graves' monoclonal and serum immunoglobulin G on adenosine 3' ,5' -monophosphate production in FRTL-5 thyroid cells:

a potential clinical assay. J Clin Endocrinol Metab 57:782, 1983

227. Macchia E, Concetti R, Carone G, et al: Demonstration of blocking immunoglobulins G, having a heterogeneous behaviour, in sera of patients with Graves' disease: possible coexistence of different autoantibodies directed to the TSH receptor. Clin Endocrinol (Oxf) 28:147, 1988

228. Takasu N, Yamada T, Takasu M, et al: Disappearance of thyrotropin- blocking antibodies and spontaneous recovery from hypothyroidism in autoimmune thyroiditis. N Engl J Med 326:513, 1992

229. Kasagi K, Tamai H, Morita T, et al: Role of thyrotropin receptor antibodies in the development of thyrotoxicosis: follow-up studies on nine patients with Graves' disease. J Clin Endocrinol Metab 68:1189, 1989

230. Kasagi K, Takeuchi R, Misaki T, et al: Subclinical Grave’s disease as a

cause of subnormal TSH levels in euthyroid subjects. J Endocrinol Invest

(27)

20: 183, 1997

231. McKenzie JM, Zakarija M: The clinical use of thyrotropin receptor antibody measurements. J Clin Endocrinol Metab 72:1093, 1989

232. Committee on Hearing and Equilibrium: Guidelines for diagnosing the evaluation of therapy in Meniere’s disease. Otolaryngol Head Neck Surg 113(3):181-185, 1995

233. Morrison AW: Endolymphatic hydrops. In: Morrison AW (ed) Management of Sensorineural Deafness, pp 145-174. London/Boston:

Butterworths, 1975

234. Katsarkis A: Hearing loss and vestibular dysfunction in Meniere’s disease. Acta Otolaryngol (Stockh) Suppl 116:185-188, 1996

235. Green JD Jr, Blum DJ, Harner SG: Longitudinal follow-up of patients with Meniere’s disease. Otolaryngol Head Neck Surg 104:783-788, 1991

236. Stahle J, Friberg U, Svedberg A: Long-term progression of Meniere’s disease. Acta Otolaryngol (Stockh) Suppl 485:78-83, 1991

237. Magliulo G, Cianfrone G, Gagliardi M, Cuiuli G, D'Amico R: Vestibular evoked myogenic potentials and distortion-product otoacoustic emissions combined with glycerol testing in endolymphatic hydrops: their value in early diagnosis. Ann Otol Rhinol Laryngol 113(12):1000-5, 2004

238. Brookes GE, Coelho A: Binaural diplacusis in Meniere’s disease. In:

Filipo R, Barbara M (eds) Meniere’s Disease: Perspectives in the ‘90s, pp 31-37. Amsterdam/New York: Kugler Publ, 1994

239. Lonsbury-Martin BL, Martin GK: clinical utility of distortion product

otoacustic emissions. Ear Hear 11:90-99, 1990

(28)

240. Gibson WP: The use of electrocochleography in the diagnosis of Meniere's disease. Acta Otolaryngol Suppl 485:46-52, 1991

241. Eggerment JJ: Summating potentials in Meniere’s disease, Arch Otolaryngol 222:63-75, 1979

242. Wuyts FL, Van de Heyning PH, Van Spaendonck M, Van der Stappen A, D'Haese P, Erre J, Charlet de Sauvage R, Aran J: Rate influences on tone burst summating potential amplitude in electrocochleography:

clinical(a) and experimental(b) data. Hear Res 152(1-2):1, 2001

243. Don M, Kwong B, Tanaka C: A diagnostic test for Meniere's Disease and Cochlear Hydrops: impaired high-pass noise masking of auditory brainstem responses. Otol Neurotol 26(4):711-22, 2005

244. Choo D, Shotland L, Mastroianni M, Glenn G, van Waes C, Linehan WM, Oldfield EH: Endolymphatic sac tumors in von Hippel-Lindau disease. J Neurosurg 100(3):480-7, 2004

245. Tokumasu K, Fujino A, Naganuma H, Hoshino I, Arai M: Initial symptoms and retrospective evaluation of prognosis in Meniere's disease. Acta Otolaryngol Suppl. 524:43-9, 1996

246. Herraiz C, Tapia MC, Plaza G: Tinnitus and Meniere's disease:

characteristics and prognosis in a tinnitus clinic sample. Eur Arch Otorhinolaryngol. 263(6):504-9, 2006

247. Stahle J, Arenberg IK, Goldman G: Staging Meniere’s disease:

description of a vertigo-disability-profile. Am J Otol 2(4):357-364, 1981

248. Mateijsen DJ, Hengel PW, Kingma H, Oreel MA, Wit HP, Albers FW:

Vertigo and electronystagmography in uni- and bilateral Meniere's

disease. ORL J Otorhinolaryngol Relat Spec 63(6):341-8, 2001

(29)

249. Hughes GB, Kinney SE, Barna BP, Calabrese LH: Autoimmune reactivity in Meniere's disease: a preliminary report. Laryngoscope 93:410-7, 1983

250. McCabe BF: Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol 88:585-9,1979

251. Hughes GB, Barna HP, Kinney SE, Calabrese LH, Hamid MA, Nalepa N:

Autoimmune endolymphatic hydrops: five year review. Otolaryngol Head Neck Surg 98:221-5 ,1988

252. Hughes GB, Moscicki R, Barna BP, San Martin JE. Laboratory diagnosis of immune inner ear disease. Am J Otol: 15:198-02, 1994

253. Yoo TJ, Tomoda X, Hernandez AD: Type II collagen-incluced autoimmune inner ear lesions in guinea pig. Ann Otol Rhinol Laryngol 93 (Suppl. 113):3-5, 1984

254. Plester D, Soliman AM: Autoimmune hearing loss. Am J Otol 10:188-92, 1989

255. Salomon P, Charachon R, Lejeune JM: Indirect immunofluorescence in the investigation of rapidly progressive sensorineural hearing loss and Meniere's disease. Acta Otolaryngol 113:318-20, 1993

256. Yamanobe S, Harris JP: Inner ear-specific autoantibodies.

Laryngoscope 103:319-25, 1993

257. Veldman JE, Banada T, Meellwsen F: Diagnostic and therapeutic dilemmas in rapidly progressive hearing loss and sudden deafness. Acta Otolaryngol 113:303-6, 1993

258. Moscicki RA, San Martin JE, Quintero CH, Rauch SD, Nadol JB Jr,

Bloch KJ: Serum antibody to inner ear proteins in patients with

(30)

progressive hearing loss. Correlation with disease activity and response to corticosteroid treatment. JAMA 272(8):611-6, 1994

259. Rauch SD, San Martin JE, Moscicki RA, Bloch KJ: Serum antibodies against heat shock protein in Meniere's disease. Am J Otol 16:648-52, 1995

260. GottschIich S, Billings PB, Keithley EM, Weisman MH, Harris JP:

Assessment of serum antibodies in patients with rapidly progressive sensorineural hearing loss and Meniere's disease. Laryngoscope 105:1347-52, 1995

261. Boulassel MR, Tomasi JP, Deggouj N, Gersdorf M: Identification of beta- actin as a candidate autoantigen in autoimmune inner ear disease. Clin Otolatyngol 25:535-41, 2000

262. Boulassel MR, Tomasi JP, Deggouj N, Gersdorf M: COCH5B2 is a target antigen of anti-inner ear antibodies in autoimmune inner ear diseases.

Otol Neurotol 22:614-8, 2001

263. Barker JM: Polyendocrine autoimmunity. Curr Diab Rep 5(2):84-90.

Review, 2005

264. Betterle C, Dal Pra C, Mantero F, Zanchetta R: Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction.

Endocr 23(3):327-64, 2002, Review. Erratum in: Endocr Rev. 23(4):579, 2002

265. Gianani R, Eisenbarth GS: Autoimmunity to gastrointestinal endocrine cells in autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab. 88(4):1442-4. Review, 2003

266. Eisenbarth GS, Gottlieb PA: Autoimmune polyendocrine syndromes. N

(31)

Engl J Med. 350(20):2068-79. Review, 2004

267. Pulec L, House WF: Meniere’s disease study: three-year progress report. Int J Equilib Res 3:156-165, 1973

268. Powers WH: Metabolic aspects of Meniere’s disease. Laryngoscope 88:122-129, 1978

269. Kinney SE: The metabolic evaluation in Meniere’s disease. Otolaryngol Head Neck Surg 88:594-598, 1980

270. Evans KL, Baldwin DL, Bainbridge D, Morrison AW: Immune status in patients with Meniere’s disease. Arch Otorhinolaryngol 245:287-292, 1988

271. Brenner M, Hoistad DL, Hain TC: Prevalence of Thyroid dysfunction in patients with Meniere’s disease. Arch Otolaryngol Head neck Surg 130(2):226-8, 2004

272. Chen SH, Hung CS, Yang CP, Lo FS, Hsu HH: Coexistence of megaloblastic anemia and iron deficiency anemia in a young woman with chronic lymphocytic thyroiditis. Int J Hematol 84(3):238-41, 2006

273. Daneshpazhooh M, Mostofizadeh G M, Behjati J, Akhyani M, Robati RM:

Anti-thyroid peroxidase antibody and vitiligo: a controlled study. BMC Dermatol 6:3, 2006

274. Barker JM: Clinical review: Type 1 diabetes-associated autoimmunity:

natural history, genetic associations, and screening. J Clin Endocrinol Metab. 2006 Apr;91(4):1210-7. Epub. Review, 2006

275. Biro E, Szekanecz Z, Czirjak L, Danko K, Kiss E, Szabo NA, Szucs G,

Zeher M, Bodolay E, Szegedi G, Bako G: Association of systemic and

thyroid autoimmune diseases. Clin Rheumatol. 25(2):240-5, 2006

(32)

276. Stollberger C, Finsterer J, Brand E, Tschabitscher D: Dysarthria as the leading symptom of hypothyroidism. Am J Otolaryngol. 22(1):70-2, 2001

277. Chen P, Chen HF, Tan SW, Su MC, Ng KW, Jiang CF: Severely sustained vomiting as the main symptom in a man with thyrotoxicosis. J Chin Med Assoc. 66(5):311-4. Review, 2003

278. Kuroda H, Kida M, Watanabe H, Matsunaga T, Niitsu Y, Matsumoto M:

Basedow disease associated with Evans sindrome. Rinsho Ketsueki.

46(10):1118-22, 2005

279. Kang MY, Hahm JR, Jung TS, Lee GW, Kim DR, Park MH: A 20-year-

old woman with Hashimoto's thyroiditis and Evans' syndrome. Yonsei

Med J 47(3):432-6, 2006

Riferimenti

Documenti correlati

VISTO il Regolamento didattico di Ateneo dell’Università degli Studi di Parma approvato dal Senato Accademico e dal Consiglio di Amministrazione in data 15/12/2016, approvato

perché non …imporre che ogni farmacia si munisca di un bastone bianco? Alcune lo annoverano già nel loro catalogo. I non vedenti avrebbero coperture garantite in ogni momento

We are pleased to be able to announce that there will be special session organised by the International Neuromodulation Society (INS) which will take place during he first two days

2) Elenco del personale del quale la Ditta concorrente intende avvalersi con indicazione dei titoli posseduti e relativa certificazione delle competenze. Si specifica

vetrina: registratori di gran marca, elettrodomestici di ogni tipo, rasoi elettrici; ci sembrava di toccare il cielo con un dito; quando lui, il Ferrandi ci consentiva l’acquisto

ELS hemangiomas are usually revealed by a retrolabrynthine bone erosion with irregular margins usually described as a ‘‘moth-eaten pat- tern’’; intratumoral bone spicules

Familial expression of anii-Saccharomyces cerevisiae mannan anti- bodies (ASCA) in aff'ected and unafl'ected relatives of Crohn's disease patients.. Elsaghier A, Prantera C, Moreno

Accordingly, predominant open label smaller trials with donepezil and rivastigmine demonstrated an improvement of cognitive function in various kinds of patients with impairment